179 related articles for article (PubMed ID: 22045399)
1. Prognostic markers in patients with ascites and hepatorenal syndrome.
Nazal L; Cárdenas A
Dis Markers; 2011; 31(3):139-46. PubMed ID: 22045399
[No Abstract] [Full Text] [Related]
2. Classification of cirrhosis: the clinical use of HVPG measurements.
Albilllos A; Garcia-Tsao G
Dis Markers; 2011; 31(3):121-8. PubMed ID: 22045397
[TBL] [Abstract][Full Text] [Related]
3. Circulating Elastin Fragments Are Not Affected by Hepatic, Renal and Hemodynamic Changes, But Reflect Survival in Cirrhosis with TIPS.
Nielsen MJ; Lehmann J; Leeming DJ; Schierwagen R; Klein S; Jansen C; Strassburg CP; Bendtsen F; Møller S; Sauerbruch T; Karsdal MA; Krag A; Trebicka J
Dig Dis Sci; 2015 Nov; 60(11):3456-64. PubMed ID: 26138655
[TBL] [Abstract][Full Text] [Related]
4. ABC of diseases of liver, pancreas, and biliary system: portal hypertension-2. Ascites, encephalopathy, and other conditions.
Krige JE; Beckingham IJ
BMJ; 2001 Feb; 322(7283):416-8. PubMed ID: 11179165
[No Abstract] [Full Text] [Related]
5. Prognostic assessment in patients with hepatic encephalopathy.
García-Martínez R; Simón-Talero M; Córdoba J
Dis Markers; 2011; 31(3):171-9. PubMed ID: 22045403
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic and prognostic markers in liver cirrhosis.
Augustin S; Genescà J
Dis Markers; 2011; 31(3):119-20. PubMed ID: 22045396
[No Abstract] [Full Text] [Related]
7. 9- -fluorohydrocortisone induced ascites in alcoholic liver disease.
Denison EK; Lieberman FL; Reynolds TB
Gastroenterology; 1971 Oct; 61(4):497-503. PubMed ID: 5114641
[No Abstract] [Full Text] [Related]
8. Prognostic indicators of survival in patients with compensated and decompensated cirrhosis.
Zipprich A; Garcia-Tsao G; Rogowski S; Fleig WE; Seufferlein T; Dollinger MM
Liver Int; 2012 Oct; 32(9):1407-14. PubMed ID: 22679906
[TBL] [Abstract][Full Text] [Related]
9. [Ascites, hepatorenal syndrome and spontaneous bacterial peritonitis in patients with portal hypertension].
Kim YS
Korean J Gastroenterol; 2010 Sep; 56(3):168-85. PubMed ID: 20847607
[TBL] [Abstract][Full Text] [Related]
10. Prognostic markers in patients with cirrhosis and portal hypertension who have not bled.
Poca M; Puente A; Graupera I; Villanueva C
Dis Markers; 2011; 31(3):147-54. PubMed ID: 22045400
[TBL] [Abstract][Full Text] [Related]
11. Plasma renin concentration represents an independent risk factor for mortality and is associated with liver dysfunction in patients with cirrhosis.
Paternostro R; Reiberger T; Mandorfer M; Schwarzer R; Schwabl P; Bota S; Ferlitsch M; Trauner M; Peck-Radosavljevic M; Ferlitsch A
J Gastroenterol Hepatol; 2017 Jan; 32(1):184-190. PubMed ID: 27164413
[TBL] [Abstract][Full Text] [Related]
12. Cystatin C is a good predictor of hepatorenal syndrome and survival in patients with cirrhosis who have normal serum creatinine levels.
Ahn HS; Kim YS; Kim SG; Kim HK; Min SK; Jeong SW; Jang JY; Lee SH; Kim HS; Kim BS; Park JM
Hepatogastroenterology; 2012 Jun; 59(116):1168-73. PubMed ID: 22057374
[TBL] [Abstract][Full Text] [Related]
13. Association of left ventricular diastolic dysfunction with inflammatory activity, renal dysfunction, and liver-related mortality in patients with cirrhosis and ascites.
Kalambokis G; Christaki M; Tsiakas I; Despotis G; Lakkas L; Tsiouris S; Xourgia X; Markopoulos GS; Dova L; Milionis H
Eur J Gastroenterol Hepatol; 2024 Jun; 36(6):775-783. PubMed ID: 38526935
[TBL] [Abstract][Full Text] [Related]
14. The kidney in cirrhosis with portal hypertension.
Olteanu D; Lupu D
J Med Life; 2010; 3(2):175-7. PubMed ID: 20968204
[TBL] [Abstract][Full Text] [Related]
15. Incidence, predictive factors, and prognosis of the hepatorenal syndrome in cirrhosis with ascites.
Ginès A; Escorsell A; Ginès P; Saló J; Jiménez W; Inglada L; Navasa M; Clària J; Rimola A; Arroyo V
Gastroenterology; 1993 Jul; 105(1):229-36. PubMed ID: 8514039
[TBL] [Abstract][Full Text] [Related]
16. Nonselective β blockers increase risk for hepatorenal syndrome and death in patients with cirrhosis and spontaneous bacterial peritonitis.
Mandorfer M; Bota S; Schwabl P; Bucsics T; Pfisterer N; Kruzik M; Hagmann M; Blacky A; Ferlitsch A; Sieghart W; Trauner M; Peck-Radosavljevic M; Reiberger T
Gastroenterology; 2014 Jun; 146(7):1680-90.e1. PubMed ID: 24631577
[TBL] [Abstract][Full Text] [Related]
17. A novel scoring model for predicting mortality risk in patients with cirrhosis and hepatorenal syndrome.
Zhang S; He LL; Wang XH; Dang ZB; Liu XL; Li MG; Wang XB; Yang ZY
Eur J Gastroenterol Hepatol; 2018 Aug; 30(8):938-943. PubMed ID: 29634664
[TBL] [Abstract][Full Text] [Related]
18. [Acute Kidney Injury and Hepatorenal Syndrome].
Kim MY; Seo YS
Korean J Gastroenterol; 2018 Aug; 72(2):64-73. PubMed ID: 30145858
[TBL] [Abstract][Full Text] [Related]
19. [Acute renal failure in patients with liver cirrhosis--what to do? An update].
Gundling F; Gülberg V; Schepp W; Mann J
MMW Fortschr Med; 2008 Apr; 150 Suppl 1():22-6. PubMed ID: 18540328
[TBL] [Abstract][Full Text] [Related]
20. Ascites and hepatorenal syndrome.
Gentilini P; Vizzutti F; Gentilini A; La Villa G
Eur J Gastroenterol Hepatol; 2001 Apr; 13(4):313-6. PubMed ID: 11338056
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
